Infermedica is a leading digital health company specialized in AI-powered solutions for preliminary diagnosis and patient triage.
Infermedica mission is to make healthcare accessible, convenient and affordable for everyone worldwide, by automating primary care, from symptom to outcome.
Infermedica was founded in 2012 by Piotr Orzechowski. The company is headquartered in Wrocław, Poland.
Infermedica provides four different products: Symptom Checker, Call Center Triage, Emergency Room Triage, and Infermedica API. It tackles the problem of inappropriate use of medical services and misdiagnosis, providing insurance companies, hospitals, and health systems with a set of advanced preliminary diagnosis and triage tools.
Infermedica has developed a carefully curated AI platform that asks diagnostic questions and computes likelihoods of primary care conditions. With nearly 60,000 hours of physician work and 8,000,000 completed user checkups, they are among the most trusted vendors of symptom checking technology.
Infermedica's HIPAA-compliant AI solutions are available in 30 countries and 19 languages, and has completed more than 10 million successful health checks to date. Infermedica is used by more than 90 healthcare organizations and partners, including Allianz, Microsoft, Sana Kliniken, Optum, Gothaer, and Médis.
Infermedica is backed by One Peak, European Bank for Reconstruction and Development (EBRD), Heal Capital, Karma Ventures, Inovo Venture Partners, and others. The company raised $30M in Series B round on Jan 25, 2022. This brings Infermedica's total funding to $45M to date.